RE:I'm still sticking to my prediction that-- Tomorrow, next week, next month....I've learned regarding timelines, the lower I set my expectations, the greater the satisfaction when it arrives ; ) Regarding price, I try not to fixate on sp. For early stage/biotech/growth companies, it's all about proof of concept/future earnings being my guide. Btw, for this type of compound/tech, I have yet to see any research that doesn't support its great potential &/or mention the importance of future investigation to advance this tech from bench to bedside.
With all of that research & our current clinical data, my investment decision-making can't get more evidence-based than that. Simply let the derisking move forward & the risk-averse/uninformed remain on the sidelines...their loss, my gain.